U88: A Potential Drug Target Or Biomarker (G677772)

Target Name: SCARNA6

NCBI ID: G677772

SCARNA6

Other Name(s): U88 | Small Cajal body-specific RNA 6 | small Cajal body-specific RNA 6

U88: A Potential Drug Target Or Biomarker

SCARNA6 (U88) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the SCARNA family of proteins, which are known for their role in intracellular signaling. U88 is a specific variant of the SCARNA6 protein that has been identified as a potential drug target or biomarker.

The SCARNA family of proteins are characterized by the presence of a unique C-terminus domain that is involved in various signaling pathways. These domains are known as SCARNAs and are involved in the regulation of a wide range of cellular processes, including cell adhesion, migration, and signaling. The SCARNA6 protein is a member of the SCARNA family and is expressed in various tissues throughout the body.

U88 is a specific variant of the SCARNA6 protein that has been identified as a potential drug target or biomarker. It is characterized by the presence of a unique N-terminus domain that is involved in intracellular signaling. This domain is known as the N-terminal transmembrane domain (NTD) and is involved in the regulation of various cellular processes, including cell signaling and interactions.

The NTD is involved in the formation of the SCARNA6 complex, which is a protein-protein interaction that is involved in the regulation of various cellular processes. The NTD is also involved in the regulation of cellular signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a potential target for drugs that are designed to inhibit its activity.

In addition to its role in intracellular signaling, U88 may also be involved in the regulation of various cellular processes that are important for maintaining cellular homeostasis. For example, it may be involved in the regulation of cell volume, cell pH, and the maintenance of cellular electrical properties.

The potential utility of U88 as a drug target or biomarker is based on its involvement in the regulation of intracellular signaling pathways. This suggests that drugs that are designed to inhibit the activity of U88 may be useful in treating a wide range of cellular and physiological processes that are important for maintaining cellular homeostasis.

In conclusion, U88 is a protein that is characterized by its unique N-terminus domain, which is involved in intracellular signaling. The potential utility of U88 as a drug target or biomarker is based on its involvement in the regulation of various cellular and physiological processes that are important for maintaining cellular homeostasis. Further research is needed to fully understand the role of U88 in cellular signaling and to determine the most effective method for targeting its activity.

Protein Name: Small Cajal Body-specific RNA 6

The "SCARNA6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCARNA6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets